Austin, Texas — According to state and local economic development sources Natera plans to invest $10,000,000.00 to build out 35,000 square feet of new space in Austin. The company plans to occupy the new space at 13011A McCallen Pass in Austin, on or about January 1, 2024. According to the company website Natera is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, womens health, and organ health. Our aim is to make personalized genetic testing and diagnostics part of the standard of care to protect health and enable earlier and more targeted interventions that lead to longer, healthier lives. Where some set out to build a test, we set out to achieve a mission: change the management of disease worldwide by using DNA testing to proactively inform treatment. Through a cfDNA technology platform approach, we’ve pioneered noninvasive testing in unlimited applications each with their own potential to revolutionize care for patients. Natera includes clinicians, scientists, biostatisticians, researchers, and laboratory professionals from around the world. Our diverse teams blend a passion for patients with deep clinical, scientific, and technological roots. Nateras tests are validated by more than 100 peer-reviewed publications that demonstrate high accuracy.

To learn more about Natera, visit http://www.natera.com/

Company Contact:
Michael Brophy, Chief Financial Officer
mbrophy@natera.com
https://www.linkedin.com/in/michael-brophy-98800155/
510-826-3572

SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved